Advertisement
FOCL vs UFPT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCL is a Hold and UFPT is a Hold.
FOCL's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for FOCL turned positive on October 21, 2026. Looking at past instances where FOCL's MACD turned positive, the stock continued to rise in 36 of 41 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 56 cases where FOCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
Following a +4.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where FOCL advanced for three days, in 185 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FOCL as a result. In 73 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
FOCL moved below its 50-day moving average on November 03, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for FOCL moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for FOCL entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. FOCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: FOCL's P/B Ratio (-60.174) is slightly lower than the industry average of (11.622). P/E Ratio (-3.952) is within average values for comparable stocks, (10.683). FOCL's Projected Growth (PEG Ratio) (8.100) is very high in comparison to the industry average of (2.016). Dividend Yield (0.000) settles around the average of (0.147) among similar stocks. P/S Ratio (1.919) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
UFPT in downward trend: 10-day moving average moved below 50-day moving average on November 02, 2026
The 10-day moving average for UFPT crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for UFPT moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 27 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UFPT as a result. In 57 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for UFPT turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 38 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
UFPT moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UFPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for UFPT entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where UFPT advanced for three days, in 275 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
UFPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. UFPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.695) is normal, around the industry mean (4.170). P/E Ratio (29.917) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (5.110) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (3.449) is also within normal values, averaging (40.124).
FOCL | UFPT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 51 Fair valued | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 37 | |
SMR RATING 1..100 | 100 | 52 | |
PRICE GROWTH RATING 1..100 | 42 | 47 | |
P/E GROWTH RATING 1..100 | 19 | 27 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FOCL's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for UFPT (90) in the Containers Or Packaging industry. This means that FOCL’s stock grew somewhat faster than UFPT’s over the last 12 months.
UFPT's Profit vs Risk Rating (37) in the Containers Or Packaging industry is somewhat better than the same rating for FOCL (100) in the Biotechnology industry. This means that UFPT’s stock grew somewhat faster than FOCL’s over the last 12 months.
UFPT's SMR Rating (52) in the Containers Or Packaging industry is somewhat better than the same rating for FOCL (100) in the Biotechnology industry. This means that UFPT’s stock grew somewhat faster than FOCL’s over the last 12 months.
FOCL's Price Growth Rating (42) in the Biotechnology industry is in the same range as UFPT (47) in the Containers Or Packaging industry. This means that FOCL’s stock grew similarly to UFPT’s over the last 12 months.
FOCL's P/E Growth Rating (19) in the Biotechnology industry is in the same range as UFPT (27) in the Containers Or Packaging industry. This means that FOCL’s stock grew similarly to UFPT’s over the last 12 months.
| FOCL | UFPT | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 88% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 69% |
| Advances ODDS (%) | 3 days ago 76% | 24 days ago 82% |
| Declines ODDS (%) | 17 days ago 84% | 2 days ago 71% |
| BollingerBands ODDS (%) | N/A | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 59% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FOCL’s FA Score shows that 1 FA rating(s) are green while UFPT’s FA Score has 1 green FA rating(s).
- FOCL’s FA Score: 1 green, 4 red.
- UFPT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FOCL’s TA Score shows that 3 TA indicator(s) are bullish while UFPT’s TA Score has 3 bullish TA indicator(s).
- FOCL’s TA Score: 3 bullish, 5 bearish.
- UFPT’s TA Score: 3 bullish, 7 bearish.
Price Growth
FOCL (@Medical Distributors) experienced а -0.24% price change this week, while UFPT (@Medical/Nursing Services) price change was -4.92% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +3.68%. For the same industry, the average monthly price growth was -4.76%, and the average quarterly price growth was -15.58%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.37%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.02%.
Reported Earning Dates
FOCL is expected to report earnings on Nov 05, 2026.
UFPT is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Medical Distributors (+3.68% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
@Medical/Nursing Services (+2.37% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
FOCL and
Correlation & Price change
A.I.dvisor tells us that FOCL and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FOCL and AORT's prices will move in lockstep.
| Ticker / NAME | Correlation To FOCL | 1D Price Change % | ||
|---|---|---|---|---|
| FOCL | 100% | -5.30% | ||
| AORT - FOCL | 29% Poorly correlated | +0.55% | ||
| UFPT - FOCL | 20% Poorly correlated | -1.29% | ||
| SENS - FOCL | 20% Poorly correlated | -1.34% | ||
| STXS - FOCL | 16% Poorly correlated | -4.22% | ||
| ACH - FOCL | 12% Poorly correlated | +7.32% | ||
More | ||||
UFPT and
Correlation & Price change
A.I.dvisor indicates that over the last year, UFPT has been loosely correlated with TCMD. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if UFPT jumps, then TCMD could also see price increases.
| Ticker / NAME | Correlation To UFPT | 1D Price Change % | ||
|---|---|---|---|---|
| UFPT | 100% | -1.29% | ||
| TCMD - UFPT | 49% Loosely correlated | +8.35% | ||
| LMAT - UFPT | 42% Loosely correlated | -0.81% | ||
| ACRS - UFPT | 39% Loosely correlated | -1.58% | ||
| ATR - UFPT | 38% Loosely correlated | -1.08% | ||
| AMIX - UFPT | 37% Loosely correlated | -1.19% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VALG | 13.49 | N/A | N/A |
| Leverage Shares 2X Long VALE Daily ETF (VALG) | |||
| APIE | 37.65 | -0.06 | -0.16% |
| ActivePassive International Equity ETF (APIE) | |||
| EVLU | 39.12 | -0.23 | -0.59% |
| iShares MSCI Emerging Markets Value Factor ETF (EVLU) | |||
| AVNV | 81.10 | -0.60 | -0.73% |
| Avantis All International Markets Value ETF (AVNV) | |||
| KSTR | 16.72 | -0.43 | -2.51% |
| KraneShares China Technology & Semiconductor STAR 50 Index ETF (KSTR) | |||